$0.7604
-0.03-3.62%
At close: -
$0.7455
-0.01-1.96%
After Hours: 5:39 PM EDT
Comments
Loading...
BIO-key Intl Analyst Ratings and Price Targets | NASDAQ:BKYI | Benzinga
BIO-key Intl Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for BIO-key Intl Corp from these most-recent analyst ratings.
Analyst Ratings for BIO-key Intl
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for BIO-key Intl (BKYI) stock?
There is no price target for BIO-key Intl
What is the most recent analyst rating for BIO-key Intl (BKYI)?
There is no analyst for BIO-key Intl
When was the last upgrade for BIO-key Intl (BKYI)?
There is no last upgrade for BIO-key Intl
When was the last downgrade for BIO-key Intl (BKYI)?
There is no last downgrade for BIO-key Intl.
When is the next analyst rating going to be posted or updated for BIO-key Intl (BKYI)?
There is no next analyst rating for BIO-key Intl.
Is the Analyst Rating BIO-key Intl (BKYI) correct?
There is no next analyst rating for BIO-key Intl.
Browse analyst ratings and price targets on all stocks.